Nebulized Ketamine for the Treatment of Major Depressive Disorder

NCT06752759 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Theresa Jacob, PhD, MPH